The oral glucose tolerance test (OGTT) is poorly reproducible, time consuming and expensive. Manley et al. have developed a decision algorithm combining HbA 1c and fasting plasma glucose (FPG) to identify the need for an OGTT using 500 UK patients who were referred for OGTT with impaired fasting glucose measurements. According to the proposed algorithm:
The oral glucose tolerance test (OGTT) is poorly reproducible, time consuming and expensive. Manley et al. have developed a decision algorithm combining HbA 1c and fasting plasma glucose (FPG) to identify the need for an OGTT using 500 UK patients who were referred for OGTT with impaired fasting glucose measurements. According to the proposed algorithm:
(1) If FPG 7.0 mmol/L: suggestive of diabetes, confirm with second glucose measurement; (2) If FPG ,7.0 mmol/L and HbA 1c ,6.0%: diabetes not present; (3) If FPG ,7.0 mmol/L and HbA 1c 6.0%: refer for OGTT.
On analysis of the 500 patients used to derive the algorithm, HbA 1c 6.0% had poor sensitivity (83%) and specificity (46%) in isolation for the diagnosis of diabetes. However, combining the HbA 1c and FPG to identify the need for an OGTT gave improved diagnostic sensitivity and specificity. The algorithm was then validated in a further 500 UK patients and in 1175 unselected Australian patients who had been referred for an OGTT. The algorithm identified 234/241 patients with diabetes in the validation cohort with a sensitivity of 97% and a specificity of 100%. Of the seven patients not diagnosed, six had impaired fasting glycaemia and would therefore have continued to be monitored. In the Australian validation cohort, of whom 26% had impaired fasting glucose measurements, the algorithm identified 382/412 cases of diabetes with a sensitivity of 93% and a specificity of 100%. Isolated impaired glucose tolerance was identified in 5% of the UK validation cohort, one-third of whom had an HbA 1c ,6.0% and would not therefore have been referred using the algorithm.
The advantages of this algorithm to both the laboratory and the patient are clear. While HbA 1c in isolation is unsuitable for the diagnosis of diabetes, combining it with fasting plasma glucose increases sensitivity to acceptable levels for a diagnostic test. The authors suggest that it could reduce the number of OGTTs required by one-third.
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University Hospital of North Staffordshire, Stoke-on-Trent, UK DOI: 10.1258 DOI: 10. /acb.2009 Evaluation and management of adult hypoglycaemic disorders: an Endocrine Society Clinical Practice Guideline Cryer P, Axelrod L, Grossman A, et al. J Clin Endocrinol Metab 2009; 94:709-28 This guideline systematically reviews the evidence for the investigation of adult hypoglycaemia. Causes of hypoglycaemia in non-diabetic patients can be deduced by careful review of the history, clinical examination, routine laboratory tests and medication history. This may elucidate causes including sepsis, hepatic, cardiac, adrenal or renal failure, alcohol, antihyperglycaemic agents and other drugs.
In seemingly-well patients hypoglycaemia is defined as a plasma glucose concentration ,3 mmol/L. Under these conditions, samples should be collected for glucose, insulin, c-peptide, proinsulin, b-hydroxybutyrate, insulin antibodies and oral hypoglycaemic agents. If insulin (.18 pmol/L), c-peptide (.0.2 nmol/L) and proinsulin (.5.0 pmol/L) are increased, insulinoma should be suspected. If insulinoma is not located via imaging, the patient may have the rare disorder noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS), which can present with a similar biochemical picture. This is due to islet cell hypertrophy and can be a consequence of Roux-en Y gastric bypass. Patients with NIPHS often suffer from postprandial hypoglycaemia, and should be assessed after a mixed meal and not after an oral glucose tolerance test. Insulin autoimmune hypoglycaemia is a rare disorder and seems to occur primarily in persons of Japanese or Korean origin. Patients often have a history of autoimmune disease or exposure to sulphydryl-containing drugs. Hypoglycaemia occurs late in the postprandial stage due to uncontrolled release of insulin. Diagnosis is readily made by a high titre of serum insulin antibodies. It is also essential that accidental, surreptitious and malicious hypoglycaemia are excluded.
The investigation of patients with both hypoglycaemia and diabetes is essential. Hypoglycaemia is often under-reported: patients with type 1 diabetes may have one to two symptomatic hypoglycaemic attacks per week and one severe temporarily disabling episode a year. Patients with drug-treated diabetes should become concerned about declining diabetic control at a plasma glucose concentration of ,3.9 mmol/L, to account for the inaccuracies of glucose meters and to allow the patient time to take preventive action.
The guideline provides a useful overview of the causes, investigation and treatment in the often difficult to diagnose presentation of hypoglycaemia in the adult.
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